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1. Introduction 
As the North American population demographic shifts towards an older profile, the 
demand for regenerative therapies will rise as more people face age-related degenerative 
diseases ranging from osteoarthritis to neurological disorders such as Parkinson’s disease. 
Current treatment options focus on palliative measures to alleviate symptoms rather than 
addressing the underlying cause. Tissue engineering has emerged as an interdisciplinary 
field of work that aims to restore function to the tissues identified as the underlying cause of 
illness. The most important building blocks used in tissue engineering are living cells. These 
cells are generally obtained from one of two sources — adult tissues or embryos. Adult 
tissues have very sparse and difficult-to-isolate stem cell populations. Further, their use for 
large scale treatment is not realistic due to their limited proliferation capabilities (Thomson 
& Odorico, 2000). Embryonic stem cells (ESCs), in contrast, are rapidly emerging as a 
promising cell source due to their unique characteristics — namely their ability to readily 
proliferate in culture as well as their potential to differentiate into all cell types of the adult 
body.  
A major roadblock that has been anticipated on the path to clinical implementation of ESC 
derived cellular therapies is the labour intensive and highly variable nature of small scale 
cultures. It has been estimated that as many as 26 billion human ESCs may be required as a 
starting point for treating one patient taking into account losses during culture, inefficient 
differentiation protocols, downstream processing and purification of mature cell types 
(Ouyang & Yang 2008). Based on current small scale culture techniques, thousands of static 
tissue culture flasks and several weeks to months of culture time would be required to 
generate this number of cells (Ouyang & Yang 2008). There are notable disadvantages in 
producing this quantity of cells in static tissue culture including heterogeneity between 
flasks, lack of environmental controls, large quantities of materials, large amounts of 
incubator space and the many hours of labour required to maintain the cultures. Several 
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automated bioprocessing systems exist which aim to reduce the amount of labour required 
to maintain static cultures, however these systems are still limited by surface area which is a 
key control on mass transfer of nutrients (Terstegge et al., 2007; Terstegge et al., 2009; 
Thomas et al., 2008). More effective methods are required to generate the large numbers of 
pluripotent ESCs needed for subsequent differentiation into functional tissue types. 
Suspension bioreactors offer a means to scale-up production of ESCs in a controlled culture 
environment not bound by the same surface area limitations as static culture techniques. 
The development of protocols for bioreactor expansion of stem cells has progressed rapidly 
in the past decade. Groups have successfully cultured hematopoietic stem cells, neural stem 
cells, human pancreatic progenitor cells and more recently both mouse and human 
embryonic stem cells in suspension (Zandstra et al., 1994; Kallos et al., 1999; Chawla et al., 
2006; Cormier et al., 2006; Krawetz et al., 2009; Kehoe et al., 2010). Despite the advances in 
bioreactor design, there is still a need for optimization and standardization of suspension 
culture protocols to ensure reproducible and predictable cell populations for use in clinical 
applications. In this chapter our aim is to review recent progress in the large scale culture of 
both murine and human ESCs as well as discuss fundamental bioprocess issues to be 
considered when using stirred suspension bioreactor culture systems. 
2. Mouse embryonic stem cells as a model 
The use of animal models in medical research goes back at least a century (Mouse Genome 
Sequencing Consortium, 2002). New therapies and drugs must be assessed for safety and 
efficacy; however, testing them on humans is not an ethical or realistic option. While single 
cells have proven to be invaluable resources for many studies, intact living animals have full 
organ systems which can undergo complex disease progression dynamics. Different animal 
models serve different purposes — larger animals models such as pigs and dogs allow for 
studies complex systems (i.e. joint loading) whereas smaller ones such as mice are useful for 
studies of genetics and progression of degenerative diseases. Mice have been shown to have 
similar genetics and physiological structures to humans. They naturally develop several 
diseases (cancer and diabetes for example) typically attributed to humans and can also be 
induced to present symptoms of neurological disorders such as Alzheimer’s (see Bedell et 
al., 1997 for a review of mice models for many human diseases). Animal models such as 
mice provide an excellent means for evaluating cell therapies: it is cost effective and 
provides fast results (the murine gestational period is a matter of weeks which allows for 
quick assessment of germline transmission which is paramount in murine ESC derivation 
evaluation). 
Knowledge gained from isolation of mouse ESCs has laid a solid foundation for isolation of 
ESCs from other animals including non-human primates and ultimately humans (Bongso et 
al., 1994; Thomson et al., 1995; Thomson et al., 1998; Reubinoff et al., 2000).  Within our own 
laboratory, work with mouse cell lines has established foundation protocols for human 
studies although the methods have not been directly transferable.  Specifically, successful 
expansion of murine neural stem cells as aggregates in suspension bioreactors (Kallos & 
Behie 1999; Gilbertson et al., 2006) enabled us to develop protocols for human neural stem 
cells (Baghbaderani et al., 2010).  Similarly, expanding murine ESCs as aggregates (Cormier 
et al., 2006; zur Nieden et al., 2007) allowed us to successfully expand pluripotent human 
ESCs as aggregates in suspension bioreactors (Krawetz et al., 2010). The fact that protocols 
are not directly transferrable is expected since cells from different species have been 
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observed to present different growth morphologies, growth kinetics (doubling times, for 
example), as well as different markers for cell pluripotency and differences in associated 
signaling pathways (illustrated in Table 1).  However, from a bioengineering point of view, 
there is still tremendous value in conducting murine experiments first.   
 
 Murine ESCs Human ESCs 
Pluripotency markers   
SSEA-1 + - 
SSEA-3 - + 
SSEA-4 - + 
TRA-1-60 - + 
TRA-1-81 - + 
Oct-4 + + 
Factors that affect 
self renewal 
LIF + Serum—activates 
JAK/STAT3 pathway 1 
 
LIF+BMP (serum free) – 
activates SMAD and/or 
MAPK pathways 1 
bFGF+MEF+SR or high bFGF+SR (no 
MEFs)- suppresses BMP signalling and/or 
upregulates expression of TGF ligands, 
activation of ERK &PI3K1 
 
TGF/Activin/Nodal1 
Teratoma formation 
in vivo 
+ + 
Colony morphology 
Tight rounded 
multilayered 
Lose rounded monolayers 
Passaging Single cells Clumps 
Table 1. Summary of culture similarities and differences between mouse and human 
embryonic stem cells. Adapted from National Institutes of Health, 2009; 1 Yu & Thomson, 
2008. bFGF= basic fibroblast growth factor, BMP= bone morphogenetic protein, LIF= 
leukemia inhibitory factor, MEF= mouse embryonic fibroblasts, SR= serum replacement, 
TGF= transforming growth factor beta.  
3. Bioprocess development for suspension culture of ESCs 
Many types of cell culture systems can produce cells and tissues in culture but they can 
generally be grouped into two categories:  1. adherent culture (tissue culture flasks) and 2. 
non-adherent culture. Both cultures can further be classified as stationary (or static), where 
the culture media is not moving, or suspension, where the medium is agitated or perfused 
(Sen et al., 2010).   Conventional culture methods for propagation of ESCs use static tissue 
culture flasks (stationary adherent culture).  As this is the current standard method for ESC 
culture, it is necessary to understand the effect of static culture environment on ESCs before 
successful development of suspension culture protocols. Static culture also provides a 
baseline for comparison of cell production from suspension culture. 
3.1 Adherent culture 
In 1981, Evans and Kaufman reported that isolation and culture of pluripotent cells were 
dependent on: 1) the stage at which pluripotent cells exist in the embryo (in other words, 
day at which cells are harvested from the blastocyst), 2) explantation of sufficiently large 
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numbers of these cells from the embryo and 3) tissue culture conditions conducive to 
propagation (multiplication) of the cells rather than differentiation. These considerations 
have been the basis for isolation of mammalian ESC lines. Currently, however, the focus of 
many groups is on the third point: trying to determine the optimum combination of factors 
to support long term expansion of these cells while maintaining functionality (pluripotency 
and self-renewal). Based on their knowledge of embryonic carcinoma cells, which are 
pluripotent cells isolated from germ cell tumors, Evans and Kaufman isolated the inner cell 
mass of a mouse blastocyst and cultured the cells on a feeder layer of mitotically inactivated 
mouse embryonic fibroblasts (MEFs) in 20% serum containing medium. The resulting cells 
exhibited a normal karyotype in contrast to embryonic carcinoma cells, which did not, and 
thus the first line of mouse ESCs was derived. This reliance on a feeder layer initially 
restricted ESC research to static adherent culture conditions. Some years later it was found 
that conditioned medium was able to support the growth of murine ESCs in the absence of a 
feeder layer (Yu & Thomson, 2008). Subsequent fractionation of conditioned medium led to 
identification of leukemia inhibitory factor (LIF) as one of the key ingredients that 
supported viability (Williams et al., 1988; Smith et al., 1988 as cited in Yu & Thomson 2008). 
Standard lab scale cultures today use gelatin as a substrate for mouse ESC adherence 
together with DMEM-based medium supplemented with LIF. This combination has 
repeatedly demonstrated long term propagation of stable pluripotent cells. Table 2 
summarizes static culture conditions described in recent publications.   
Based on previous methods of ESC derivation, Bongso et al. (1994) isolated the inner cell 
mass of a human blastocyst on a feeder layer of human oviductal epithelial cells in a 
medium containing human LIF and 10% human serum. While initial colonies had promising 
morphologies, the cells either differentiated or died after only two passages. This is an 
example of difficulties encountered in transferring protocols directly between species. 
Shortly after, another group successfully derived a non-human primate ESC line (Thomson 
et al., 1995). The cells isolated from a rhesus monkey embryo were cultured on irradiated 
mouse embryonic fibroblasts in DMEM based medium supplemented with human LIF and 
20% fetal bovine serum (FBS). Although human LIF was used in the initial derivation of 
these cells, it was subsequently removed and the cells were successfully cultured for over a 
year while maintaining a stable karyotype and the ability to differentiate into all three germ 
layers. Conversely, when human LIF was used and MEFs removed, the cells differentiated 
(Thomson et al., 1995).  Based on this success, Thomson then used a similar protocol to 
derive the first human ESC lines using irradiated MEFs and DMEM medium with 10% FBS 
(Thomson et al., 1998). Subsequent work has led to the refinement of medium and 
identification of optimum substrates with many groups now reporting the use of DMEM 
with serum replacement medium or the commercially available defined medium, mTeSR™ 
with matrigel™ (an ECM extract of mouse sarcoma) as the substrate. These culture protocols 
have proven to give rise to stable pluripotent cell populations (Xu et al., 2005; Ludwig et al., 
2006; Levenstein et al., 2006). Table 3 provides a brief summary of static culture conditions 
reported in recent publications of human ESCs. It is apparent that these small scale adherent 
culture conditions are well suited to most laboratory research. However, if we look to the 
future of stem cell based therapies in clinical settings, these small scale culture techniques 
are simply not feasible on a large scale. 
Ouyang & Yang (2008) provided a useful summary of cell numbers estimated to be required 
for different clinical applications. For treatment of an adult with leukemia, they calculated 
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Reference Cell Lines Substrate Medium Passaging 
Kehoe 2008 E14Tg2a 
 
0.1% Gelatin DMEM+10%FBS TrypLE 
Veraitch 
2008 
E14Tg2a 
 
0.1% Gelatin GMEM+10%FBS Trypsin 
Abranches 
2009 
E14Tg2a 
46C 
S25 
 
0.1% Gelatin GMEM+10%FBS Not specified 
for 
maintenance 
conditions 
Fernandes, 
TG 2009 
46C 0.1% Gelatin DMEM+10%FBS 
ESGRO complete 
KO-DMEM+15%KSR 
 
Trypsin, 
Accutase 
Marinho 
2009 
USP-1 Gelatin 
MEFs 
DMEM/F12+15%KSR+CHO-
CM (for LIF)- changed every 2 
days 
TrypLE 
Alfred 2010 D3 Gelatin DMEM+15%FBS Not specified 
for static 
 
Jing 2010 E14Tg2a 0.1% Gelatin DMEM+10%FBS 
 
TrypLE 
Taiani 2010 D3 MEFs DMEM+15%FBS Not specified 
for static 
Ito 2010 E14Tg2a 
J1 
Gelatin 
MEFs 
GMEM+15%FBS Not specified 
 
 
Table 2. Summary of recent publications with static maintenance of murine ESCs. DMEM= 
Dulbecco’s Modified Eagle’s Medium, GMEM= Glasgow’s Minimal Essential Medium, KO-
DMEM= KnockOutTM DMEM (Inivitrogen), KSR= KnockOutTM Serum Replacement 
(Invitrogen), ESGRO Complete= defined serum-free medium (Chemicon/Millipore)- 
contains LIF, CHO-CM= Chinese Hamster Ovary Conditioned Medium. Unless otherwise 
stated, culture medium also included LIF, 2-mercaptoethanol and non-essential amino acids. 
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Reference Cell Lines Substrate Medium Passaging 
Peerani 2008 H9, CA1, I6 MEFs 
Matrigel 
KO-DMEM+20%KSR+bFGF 
XVIVO10+bFGF+TGFb1 
Collagenase 
Bauwens 2008 H9,  
H2B 
MEFs KO-DMEM+20%KSR+bFGF Collagenase 
Niebruegge 
2008 
H9,  
HES2 
Matrigel 
MEFs 
XVIVO10+bFGF+TGFb1 
KO-DMEM+20%KSR+bFGF 
Collagenase 
Phillips 2008a ESI-017 HFF+ 
Fibronectin 
Fibronectin 
KO-DMEM+20%KSR+bFGF 
HFF-CM 
Collagenase 
NB6 
Bendal 2009 H1, H9 Matrigel MEF-CM with and without 
bFGF 
Collagenase 
Fernandes 
2009 
H9 MEFs DMEM/F12+20%KSR+bFGF TrypLE 
Gibson 2009 H9 MEFs DMEM/F12+20%KSR+bFGF Collagenase 
Hentze 2009 HES2, HES3, 
HES4, 
ESI-014, 017, 
035, 049, 051, 
053 
HFFs KO-DMEM+20%KSR+bFGF Collagenase, 
TrypLE 
Lee 2009 H9, I6, HES2 MEFs KO-DMEM+20%KSR+bFGF Not specified 
Lock 2009 H1, H9 MEFs 
Matrigel 
DMEM/F12+20%KSR+bFGF 
MEF-CM+bFGF 
Collagenase 
Montes 2009 HSI81, 
SHEF1 
Matrigel MSC-CM + bFGF  
HFF-CM +bFGF 
Collagenase 
Nie 2009 H1, H9 MEFs 
Matrigel 
DMEM/F12+20%KSR+bFGF 
MEF-CM + bFGF 
Collagenase 
Oh 2009 HES2, HES3 Matrigel MEF-CM + bFGF Collagenase 
Amit 2010 I3, I4, I6, 
H9.2 
MEF DMEM/F12+15%KSR+bFGF Collagenase 
Chen 2010 HES2, HES3 Matrigel mTeSR, MEF-CM, StemPRO TrypLE 
Krawetz 2010 H9 HFF 
Matrigel 
mTeSR Collagenase+
TrypLE 
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Reference Cell Lines Substrate Medium Passaging 
Singh 2010 HES2, HES3, 
ES1049 
HFF KO-DMEM+20%KSR+bFGF TrypLE 
Larijani 2011 Royan H5, 
H6, hiPSC1, 
hiPSC4 
Matrigel DMEM/F12+20%KSR+bFGF 
 
Not specified 
for adherent 
cultures 
Leung 2011 HES2, HES3 Matrigel MEF-CM+bFGF Enzymatic 
Table 3. Summary of recent publications with static maintenance of human ESCs. bFGF = 
basic fibroblast growth factor, TGFb1= transforming growth factor beta 1, XVIVO10= serum 
free medium (Lonza), HFF-CM= human foreskin fibroblast conditioned medium, MEF-CM= 
mouse embryonic fibroblast conditioned medium, mTeSR= serum-free defined medium 
(STEMCELL Technologies), StemPRO= serum-free defined medium (Invitrogen). 
that 2.1x1010 cells would be required per treatment. If one T-75 culture flask supports the 
production of 2x106 cells in 2-3 days, production of 2.1x1010 cells would require over 10,000 
tissue culture flasks and up to 5 weeks of culture time (Ouyang & Yang, 2008).  They also  
determined flask count and time estimates for Parkinson`s disease and diabetes. In both 
cases similarly large numbers of tissue culture flasks were calculated. The handling of this 
number of tissue culture flasks would be extremely labor-intensive.  Additionally, this type 
of culture lacks continuous monitoring and environmental controls that may result in 
spontaneous stem cell differentiation. Alternatively, suspension bioreactors provide a 
controlled environment to produce the same number of cells. Studies from our lab have 
produced densities of mouse ESCs in suspension of approximately 1-2x106 cells/mL (Alfred 
et al., 2010; Cormier et al., 2006). As such, production of clinical numbers would require 
suspension volumes of the order of liters. 
3.2 Suspension bioreactor culture 
There have been arguments that not enough is known about ESCs to take them out of 
adherent cultures and culture them in suspension conditions as reduced adhesion in 
anchorage dependent cells has been associated with disorganized growth patterns and 
changes in cell-to-cell contact (Freshney, 2000). However, the final test of success for any 
new culture format is the functionality of the cells. Refinement of suspension culture 
protocols to ensure stable karyotypes, continued expression of pluripotency markers as well 
as demonstration of pluripotency through embryoid body and/or teratoma formation is the 
goal of embryonic stem cell bioprocess development.  
It is clear upon review of recent publications that culture conditions vary a great deal 
between mouse and human ESCs as illustrated in Tables 4 and 5, respectively. Mouse ESCs 
were able to readily form aggregates in suspension whereas human ESCs required the 
addition of ROCK inhibitor to survive non-adherent conditions and form aggregates. As for 
differences within each cell type, it is clear that there is greater variation between different 
human ESC protocols than between different mouse ESC protocols. As murine ESCs were 
established years before human ESCs, culture medium and passaging techniques are far 
more standardized and suspension protocols appear to be fairly similar between 
publications. 
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While these studies illustrate that it is possible to culture human ESCs in suspension (i.e. 
proof of concept), work must be done with respect to optimization and standardization of 
protocols. An understanding of key culture variables is necessary to achieve this. 
 
Reference Cell Lines Inoculation 
Density 
(cells/mL) 
Medium Passaging Spinner 
Type 
(Volume) 
Agitation 
Rate (rpm) 
Fok 2005 R1, CCE 5x104 DMEM+15%FBS Trypsin Bellco 
(50 mL) 
 
60,100 
Cormier 2006 R1 3.75-10x104 DMEM+15%FBS 
 
Trypsin Corning 
(100 mL) 
 
60-120 
Zur Neiden 
2007 
R1 3.75x104 DMEM+15%FBS Trypsin NDS 
(100 mL) 
 
100 
Hwang 2008 E14Tg2a 3.0x105 DMEM+10%FBS N/A Synthecon 
(50 mL) 
 
25 
Kehoe 2008 E14Tg2a 1-7.5x104 DMEM+10%FBS 
DMEM+10-20% 
KSR 
 
TrypLE Corning 
(100 mL) 
60-120 
Tsuji 2008 D3, E14, 
EB5 
(1-500)x104 DMEM+15%FCS Trypsin 96 well 
plates 
 
N/A 
Alfred 2010 D3 3.75x104 DMEM+15%KSR Trypsin NDS 
(100 mL) 
100 
Table 4. Summary of suspension culture conditions for undifferentiated murine ESCs as 
aggregates. Unless otherwise stated, culture medium also included LIF, 2-mercaptoethanol 
and non-essential amino acids. 
Reference Cell 
Lines 
Inoculation 
Density 
(cells/mL) 
Medium Passaging Bioreactor 
Type 
Agitation 
Rate 
(rpm) 
Kehoe 2010 H1 6.0x104 MEF-CM+ 
Matrigel+ROCK 
 
Accutase+ 
ROCK 
Not 
specified 
60 
Krawetz 
2010 
H9 1.8x104 mTeSR+ROCK+ 
rapamycin 
 
Accutase+ 
ROCK 
NDS 
(100mL) 
100 
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Reference Cell 
Lines 
Inoculation 
Density 
(cells/mL) 
Medium Passaging Bioreactor 
Type 
Agitation 
Rate 
(rpm) 
Amit 2010 I3, I4, I6, 
H9.2 
1-5x106 DMEM/F12+KSR+ 
bFGF 
DMEM/F12+KSR+ 
bFGF+IL6RIL6 
DMEM/F12+KSR+ 
bFGF+LIF 
DMEM/F12+KSR+ 
bFGF+IL6 
 
Collagenase 
Trypsin+ 
ROCK 
Erlenmeyer 
(25mL) 
90 
Olmer 2010 HES3 0.3x105 mTeSR+/-ROCK 
KO-DMEM+ 
KSR+bFGF+/-ROCK 
KO-DMEM+FBS +/-
ROCK 
 
Collagenase 6well plate NA 
Singh 2010 HES2, 
HES3, 
ES1049 
2.5x105 
1x106 
1x106 
KO-DMEM+20%KSR 
+bFGF 
mTeSR 
Collagenase 
+TrypLE+ 
ROCK 
Low att. 
plate 
Stirred dish 
(10mL) 
CELLSPN 
(100mL) 
 
NA 
35 
40 
Steiner 
2010 
HES1, 
HES2, 
H7 
0.37-1.2x106 KO-DMEM+14%KSR 
+bFGF +Activin A+ 
fibronectin+ laminin+ 
gelatin+BDNF+NT3 
+NT4+Nutridoma-CS 
 
Collagenase 
Trituration+ 
ROCK 
12well plate NA 
Larijani 
2011 
Royan 
H5, H6, 
hiPSC1, 
hiPSC4 
15x104 DMEM/F12+20%KSR
+ bFGF 
MEF-CM+bFGF 
MEF-CM+bFGF+ 
N2+B27 
(all with ROCK) 
 
Trypsin+ 
ROCK 
6well plate NA 
Table 5. Summary of suspension culture conditions for human ESCs as aggregates. ROCK = 
p160-Rho-associated coiled kinase inhibitor (Y-27632) (Watanabe et al., 2007). 
3.2.1 Suspension bioreactor design considerations 
Traditional reactor types that may be used in biological processes include batch reactors, 
continuous stirred tank reactors, and plug flow reactors. Bioreactors support and control 
living biological entities and therefore require process control and stringent steps to 
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eliminate contamination (Williams, 2002). Mammalian cells are far more sensitive to culture 
conditions and far less stable with respect to maintenance of cell functionality than many 
other cell types such as yeast, bacteria and fungi. Additionally, shear is normally not a 
concern for these cell types whereas ESCs are far more sensitive to their environment. 
Human ESCs for example will spontaneously transform, differentiate or undergo apoptosis 
as a reaction to small changes in culture conditions (Chu & Robinson, 2001). This becomes a 
challenge as mixing is an integral consideration in reactor design for nutrient and oxygen 
mass transfer and the requirement of achieving target shear places an additional constraint 
on agitation speed (Schmidt, 2005). The aim of bioreactor design is to minimize the cost of 
production while retaining the desired quality of the product all within biological, fluid 
mechanical, and mass transfer constraints (van’t Riet & Temper, 1991). With stem cells, the 
objective is to robustly produce large quantities of viable undifferentiated cells for further 
differentiation and purification steps. Downstream processing will be the cost determining 
step and therefore the goal is maximization of product concentration obtained from the 
bioreactors (van’t Riet & Temper, 1991). To accomplish this, some key design areas must be 
considered including: materials (bioreactor walls and agitators), medium (chemical 
composition, pH, temperature), rheological conditions (fluid dynamics and mass transfer 
systems), and residence time of cells within the bioreactor. Issues such as temperature, pH, 
and medium formulation are fairly well defined for human ESC culture (King & Millar, 
2007). Areas that are less understood with respect to suspension culture are those of the 
physical and geometric properties of the bioreactor itself. Parameters falling within this area 
are broad ranging from rheology and hydrodynamics, to mixing and agitator design, to heat 
and mass transfer, to issues of scale up and process control. Throughout the work within 
our lab group we have observed that culture parameters with the largest impact on cell 
populations are agitation rate, inoculation density and oxygen transfer. 
3.2.2 Agitation speed 
The rate of agitation within a stirred suspension bioreactor is an important consideration as 
it affects not only the mixing of oxygen and nutrients within the medium, but it also 
maintains cell aggregate sizes and keeps cells in suspension. However, development of 
effective bioprocesses for suspension culture requires an understanding of the nature of the 
biomass within the reactor. Embryonic stem cells along with many other mammalian cell 
types have been observed as being extremely sensitive to shear (Garcia-Cardena & Adamo, 
2011; Toh & Voldman, 2011). While the medium must be agitated at a speed sufficient to 
ensure nutrient mixing, this speed must also be kept within limits so as not to exert undue 
shear on the sensitive biomass. We therefore need to understand the forces caused by 
agitation, how these forces act on cells, how we can quantify these forces, and the 
relationship between the forces and cell viability. There have been a very few reports on the 
effect of shear in stirred bioreactors on murine ESC growth. Cormier et al., (2006) found that 
aggregate diameter correlated with agitation rate but did not quantify the correlation.  To 
date there have not been any comprehensive investigations into shear effects on growth 
kinetics in human ESC suspension cultures.  
3.2.3 Inoculation density 
Inoculation density is an important parameter that tends to be taken for granted in many 
studies. In our lab, we have seen that when inoculating suspension spinners, too few cells 
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will fail to initiate agglomeration and therefore aggregates do not form and cells die due to 
lack of cell-to-cell interaction. Too many cells may form massive aggregates that create 
issues with oxygen transfer to cells at the aggregate centre (necrosis). Additionally, rapid 
depletion of nutrients in the medium and subsequent rapid build-up of waste materials can 
adversely affect growth and expansion of the cell population (Sen et al., 2010).  
In general, inoculating at the lowest possible cell density allows for maximum cell number 
amplification, however many have observed that this also causes a longer lag phase which 
results in an extended culture period required to reach maximum cell density. Extremely 
low and high initial densities have been observed to affect the exponential growth 
phase with a reduction in specific growth rates (Cormier et al., 2006; Fernandes, TG et al., 
2009).  
A review of literature fails to turn up a great deal of further information on inoculation 
densities with respect to ESC culture. With human ESCs the passaging techniques used 
(passaged as clumps until recently) prevented quantification of cells.  
3.2.4 Nutrient and oxygen uptake 
Oxygen is essential for cell proliferation and viability. In smaller vessels, surface aeration as 
the main mode of oxygen supply is typically sufficient and commonly used due to its 
simplicity. However, as culture volumes increase and cell densities increase, the surface area 
to volume ratios decrease and surface aeration may no longer be sufficient to ensure oxygen 
transport to the cells (Gilbertson et al., 2006; Baghbaderani et al., 2008). Options to increase 
oxygen transport include increasing agitation rate of the impeller, sparging, or medium 
additives such as Perfluorocarbons (PFCs) which increase oxygen solubility within the 
liquid medium. To determine which method is best, the oxygen requirements of the system 
must be determined. 
Starting with the basic mass conservation equation for a specific component within a control 
volume (in this case the oxygen within the liquid cell culture medium), we have: 
 Input + Generation = Output + Accumulation (1) 
The input of oxygen into the medium, also known as the oxygen transfer rate (OTR), by 
using surface aeration only (no sparging) is controlled by the concentration difference 
between the headspace of the vessel and bulk medium oxygen concentration. Since no 
oxygen is released from the system, the output term is zero. The accumulation term refers to 
the rate of change in oxygen concentration within the medium while the generation term 
actually refers to the oxygen uptake rate (OUR) of the cells which is negative to indicate the 
cells are consuming oxygen rather than producing it. With this in mind, the material balance 
becomes:   
 OTR – OUR = 0 + dCO2/dt (2) 
where OTR and OUR are as follows: 
 OTR = kLa CO2 (3) 
 OUR = qO2X (4) 
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where kLa is the volumetric mass transfer coefficient, CO2 is the difference in oxygen 
concentration between oxygen saturation concentration in the bulk medium (CO2* which 
may be determined via Henry’s law for an assumed partial pressure of 20% O2 in normal 
incubator air with 5% CO2) and the measured bulk medium concentration (CO2). The term 
qO2 is the specific oxygen uptake rate of the cells and X is the cell density within the medium 
(Garcia-Ochoa & Gomez., 2009).  
Rearranging Equation 2 yields an expression for the rate of change in oxygen concentration 
within the bulk medium: 
 dCO2/dt = kLa CO2 – qO2X (5) 
As can be seen from the preceding equations, the kLa value is the unknown when 
determining the rate of oxygen transfer. There have been numerous methods described for 
the determination of the mass transfer coefficient depending on the nature of the system: 
factors such as aeration, vessel design, medium composition and the effect of the presence of 
a microorganism must all be taken into account.  
Throughout the literature there have been many attempts to develop empirical relationships 
for the determination of kLa. These relationships are sometimes based on both dimensional 
and dimensionless values. Garcia-Ochoa & Gomez (2009) have presented a very 
comprehensive summary of a number of published correlations for the determination of kLa 
in stirred suspension bioreactors. Upon review, it is apparent there is considerable variation 
between the correlations presented. For example, in 1979, Van’t Riet & Temper proposed a 
correlation based on the power input per unit volume (P/V) but stated there was no 
influence of the impeller geometry and placement within the bioreactor. Subsequent studies 
contradicted this statement by showing that changing the impeller geometry alone caused 
an increase in mass transfer rate and a change in impeller placement also had an effect (See 
Garcia-Ochoa & Gomez, 2009 for a full review). To date there still does not appear to be a 
firm consensus as to which correlation is best suited for the determination of kLa in a stirred 
vessel.  
The wide range of empirical relationships developed may in part be due to the similarly 
wide range of protocols for the experimental determination of kLa. For culturing stem cells, 
the presence of the cells themselves is assumed to have a large impact on mass transfer in 
the system. As such, the biomass present within the system is the main consideration when 
determining kLa values experimentally. There have been thorough reviews elsewhere which 
have described several approaches to experimentally determine kLa (Garcia-Ochoa & 
Gomez., 2009). One example that we have used, described by Baghbaderani et al. (2008), is 
as follows.  Briefly, the assumption is made that at some point in time the reactor reaches 
steady state during which any oxygen entering the medium would be immediately 
consumed by the cells (that is, CO2 equals zero in the medium). At this point the maximum 
cell density is attained and the limiting rate of oxygen transfer is reached. In this instance 
oxygen transfer into the medium equals the oxygen uptake rate of the cells and there would 
be no change in the oxygen concentration in the bulk liquid. In other words the rate of 
change in oxygen concentration is zero (dC/dt=0). Equation 5 then simplifies to: 
 kLa = qO2 X / CO2* (6) 
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The specific oxygen uptake (qO2) of the cells in the system can be determined by measuring 
the oxygen concentration in medium without cells and then placing a known number of 
cells in the medium and sealing off the vessel with no headspace to replenish the oxygen. 
Measurements of the oxygen concentration in the medium are taken over time and the 
resulting rate of oxygen decrease is directly attributed to the uptake by the cells in the 
medium. That is: 
 dCO2/dt = qO2X (7) 
Once the specific uptake rate for a cell type is known, the limiting kLa value for a desired cell 
concentration can be determined. This method, however, obviously does not take into 
account any dimensional effects of the system. As such, Baghbaderani et al. (2008) have 
recommended a correlation put forth by Aunins et al. (1989) for a 500mL Corning spinner 
which takes the following form: 
 kLa = 1.08 Re0.78 [DO2 a / DT] (8) 
Where Re and DO2 are the Reynolds’ number (dimensionless) and diffusion coefficient of 
oxygen (m2 s-1) in the bioreactor medium, a, is the specific mass transfer interfacial area 
(taken as surface area/volume, m-1) and DT is the tank diameter (m). Determining this value 
based on system parameters and then comparing to the kLa determined experimentally for 
the cell type allows for an indication of whether or not oxygen transfer limitations exist 
within the system. 
3.3 Suspension bioreactor culture of ESCs on microcarriers 
Microcarriers are small, usually spherical or nearly spherical beads on which adherent cell 
types may grow. These beads are available in a multitude of materials including gels, 
polymers, and collagen.  Based on their surface topography, they are generally described as 
macroporous (allowing cells to expand within the microcarrier), microporous (cell 
attachment occurs on the surface of the microcarrier, however, cells are exposed to medium 
on the attached surface as well), or non-porous microcarriers (cells are exposed to medium 
only on surfaces not attached to the microcarrier). When added to a suspension bioreactor, 
microcarriers provide high surface area to volume ratio which enables higher cell densities 
compared to that obtained in static culture. This area can be adjusted by varying the number 
of microcarriers in the culture (see Table 6 for a summary of microcarrier types and 
specifications). Microcarriers in cell culture offer several advantages including: better 
control of culture macro-environment within bioreactors compared to static tissue cultures 
and roller bottles, a reduction in labor costs, ease of downstream clinical applications as cells 
can be transplanted while on microcarriers, significant reduction in the space required for a 
given-sized operation and hence higher cell densities per unit volume. In addition, by 
allowing cells to grow on a surface, microcarrier cultures harness all the advantages of a 
static tissue culture system, as well as the controlled environment of a bioreactor system. 
This provides the cells direct exposure to the medium and reduces mass transfer limitations 
of oxygen and nutrients. Comprehensive reviews on microcarrier materials and 
specifications as well as their role in tissue engineering can be found elsewhere (GE 
Healthcare, 2005; Martin et al., 2011).  
Though it has been over four decades since microcarriers were developed (Van Wezel, 
1967), only recently have microcarriers been investigated as suitable scaffold materials for  
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Type Company Core Material Surface 
Coating 
Density 
(g/cm3) 
Bead 
Diameter 
(m) 
Surface 
Area 
(cm2/g) 
CultiSpher S Percell 
Biolytica 
Crosslinked 
pharmaceutical 
grade gelatin 
 
Porcine 
gelatin 
1.04 130 – 380 7500 
Collagen 
  
SoloHill 
Engineering 
Crosslinked 
Polystyrene, 
modified with 
gelatin 
 
Type1 porcine 
gelatin 
1.02 90-150 480 
Fact III 
  
SoloHill 
Engineering 
Crosslinked 
Polystyrene, 
modified with 
cationic gelatin 
 
Cationic, 
type1 porcine 
gelatin 
1.02 90-150 480 
Glass SoloHill 
Engineering 
Crosslinked 
Polystyrene, 
modified with high 
silica glass 
 
High silica 
glass 
1.02 125-212 360 
Pronectin F SoloHill 
Engineering 
Crosslinked 
Polystyrene, 
modified with 
recombinant 
fibronectin 
 
Recombinant 
fibronectin 
1.02 125-212 360 
Hillex II SoloHill 
Engineering 
Modified 
Polystyrene, 
modified with 
cationic trimethyl-
ammonium 
 
Cationic, 
trimethyl 
ammonium 
1.11 160 - 180 515 
Cytodex 3 Amersham 
Biosciences 
Crosslinked dextran,  
Denatured Collagen 
on the surface 
 
Porous 
Porcine 
gelatin 
1.04 141 - 211 
 
2700 
Cytodex 1 Amersham 
Biosciences 
Crosslinked Dextran 
with N,N-
diethylaminoethyl 
groups 
Porous 
Porcine 
gelatin 
Cationic 
1.03 147-248 4400 
 
Table 6. Summary of some of the commercially available microcarriers for cell culture 
(adapted from Alfred et al., 2011). 
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cultivation of ESCs (as shown in Tables 7 and 8). However, several issues need to be 
resolved before ESCs produced on microcarriers and their progeny can be used in drug 
discovery and regenerative medicine applications, respectively. These issues include 
excessive agglomeration, which has been shown to be detrimental to cell expansion  as a 
result of necrotic centers (Borys and Papoutsakis 1992), mediocre to low cell yields 
(especially for human ESC cultures), as well as the elimination of serum and MEFs used in 
microcarrier cell cultures. Finally, lack of attachment of cells to the microcarriers and the 
formation of cystic structures in suspension (Abranches et al., 2007; Nie et al., 2009; Storm et 
al., 2010) must also be addressed to eliminate heterogeneities in cultures. 
4. Future directions for large scale production of human ESCs 
The publications summarised in Tables 6 and 7 coupled with our own initial successes 
culturing human ESCs in suspension are a promising step towards development of 
strategies for implementation of stem cell therapies on a large scale. However, it is also quite 
apparent that major discrepancies exist in protocols between lab groups. Significant cell- 
manufacturing and regulatory challenges must be overcome before clinical application of 
stem cell therapies will be viable. It must be noted that standards and methodologies are 
only just being developed for efficacy evaluation, product characterization and process 
validation and control. As such, human ESC culture must be approached as a 
multidimensional optimization problem with the goal to increase target cell output while 
decreasing cost and occurrences of adverse events (Kirouac & Zandstra, 2008). In 2008, 
Kirouac & Zandstra suggested that process design and optimization should incorporate: i) 
assessment of relevant cell properties, ii) measurement and control of key parameters, iii) 
robust predictive strategies for evaluating the parameters that may impact culture output, 
iv) approaches to test these many different parameters in a high throughput and scale 
relevant manner.  
Development of predictive strategies includes computer modeling methods to assist in 
prediction of culture outcomes based on various input parameters with their inherent 
uncertainty. To date, many groups have used mathematical modeling techniques to describe 
 cell proliferation in a variety of systems (Mantzaris et al., 2001; Galban & Locke., 
1999;Lemon et al., 2007) as well as differentiation (Lemon et al., 2007; Yener et al., 2008; 
Prudhomme et al., 2004). This modeling approach is limited as only a small number of input 
variables can be considered to maintain the practicality of derived relationships and ease of 
computation. Empirical or correlation models on the other hand, do not rely on 
mathematically describable relationships between input and output variables. Some 
researchers have used factorial design for process optimization by using response surface 
maps that approximate relationships between variables and outcomes (Chung et al., 2006; 
Audet, 2010).  
Both of these modeling approaches are reasonable and practical when the input variables 
are limited and generated data sets are of a manageable size. When these data sets become 
increasingly large, for example, using tools such as microarrays, other methods of analysis 
are beginning to surface. Methods such as neural networks and statistical learning methods 
may prove to be very useful. These algorithms learn by example, or are trained by a data set, 
to assign labels to objects and recognize patterns within very large amounts of data. The use 
of these methods has yet to be fully defined within biological systems but it is apparent that 
the process is underway (Nobel, 2006). 
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Reference Cell 
Lines 
Medium Passaging/ 
Harvesting 
Inoculation 
Density 
(cells/mL) 
Microcarrier 
Type 
Agitation 
Rate (rpm) 
Fok 2005 CCE, R1, 
M8, 
9J 
DMEM+15%FBS Trypsin 5x104 Cytodex 3, 
Glass coated 
styrene 
60 
Abranches 
2007 
 
S25 GMEM+10%FBS Trypsin 1x104, 5x104 
or 1x105 
Cytodex 3 60 
Fernandes 
2007 
 
46C DMEM+10%FBS 
ESGRO Complete 
Trypsin 5x104 Cytodex 3, 
Cultispher S 
40 
Phillips 
2008b 
 
R1 MEF-CM Trypsin 1x105 Hillex II 40 
Marinho 2009 USP-1 MEF-CM + 
DMEM/F12 + 
15%KSR + CHO-
CM 
 
TrypLE 2x105 Cytodex 3 70 
Storm 2010 E13tg2a KO-DMEM+ 
20%KSR 
GMEM+10%Serum 
Trypsin 6x104 Collagen, 
FACT, 
Cultispher S 
45 
Table 7. Summary of suspension culture conditions for mouse ESCs on microcarriers. 
Medium components listed are only the base. See references for full medium components. 
 
Reference Cell 
Lines 
Medium Passaging/ 
Harvesting 
Inoculation 
Density 
(cells/mL) 
Microcarrier 
Type 
Agitation Rate 
(rpm) 
Phillips 
2008b 
ESI-017 HFF-CM TrypLE 6.25x104 Hillex II Not specified 
Fernandes 
2009 
H9 MEF-CM TrypLE 2-2.5x105 Cytodex 3 60 
Lock 2009 H1, H9 DMEM/F12+ 
20%KSR+bFGF 
TrypLE 5-20x104 Collagen+ 
Matrigel 
coated 
 
45-80 
Nie 2009 H1, H9 MEF-CM + 
bFGF 
Trypsin 3-7x104 
cells/cm2 
Cytodex 3+ 
MEFs or 
matrigel 
 
6well plate on 
rocker 
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Reference Cell 
Lines 
Medium Passaging/ 
Harvesting 
Inoculation 
Density 
(cells/mL) 
Microcarrier 
Type 
Agitation Rate 
(rpm) 
Oh 2009 HES2, 
HES3 
MEF-CM, 
mTeSR1, 
StemPRO 
TrypLE 
Collagenase 
Mechanical 
2x105(6well) 
6x105(spinner) 
Matrigel 
coated 
cellulose 
 
100 (6well) 
25(spinner) 
Chen 2010 HES2, 
HES3 
MEF-CM 
mTeSR 
StemPRO 
 
Mechanical 2x105 DE-53+ 
matrigel 
120(6well) 
Storm 2010 SHEF-3 MEF-CM+bFGF 
KO-DMEM+ 
20%KSR 
 
Trypsin+ 
ROCK 
6x104 Cultispher S 45 
Serra 2010 SCED-
461 
MEF-
CM+ROCK 
 
TrypLE 1.5,3,4.5x105 
 
4.5x105 
Cytodex 3 100mL 
Wheaton 
24rpm 
300mL 
BIOSTAT 50-
65rpm 
 
Leung 2011 HES2, 
HES3 
MEF-CM Mechanical 0.8-6x105 (6well) 
3.2-6x105 
(spinner) 
DE-53 100-120(6well) 
25(spinner) 
Table 8. Summary of suspension culture conditions for human ESCs on microcarriers. 
Medium components listed are only the base. See references for full medium components. 
As computational methods become more refined along with our understanding of biological 
processes, it is clear that regenerative medicine will benefit. The use of modeling and scale 
up techniques has the potential to bring stem cell based therapies into mainstream 
application and greatly benefit those suffering from debilitating degenerative diseases. 
5. Conclusions 
Overall, though considerable progress has been made in the development of bioprocesses for 
the production of ESCs and their progeny, it is obvious that more basic research is needed 
prior to downstream application of these cells. While protocols developed so far have focused 
on scaling up production of ESCs and their derivatives, other fundamental issues including 
elimination of animal derived products in ESC cultures, immune rejection and tumor 
formation upon transplantation of ESC derivatives must also be addressed. Utilization of 
modeling techniques to address possible outcomes of interaction effects of various variables 
involved will be a cost effective method to address some of these issues.  Finally, it will be 
necessary to develop optimized robust, controllable systems in production facilities designed 
to meet the manufacturing requirements established by various governing bodies. 
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